C-Rad
30,25 SEK -0,33%1 investor følger denne virksomhed
C-Rad is active in medical technology. The company conducts the development, manufacturing, and sales of products and solutions in advanced radiation therapy. The business is mainly aimed at clinics that offer radiation treatment, where the company in addition to its core business offers associated installation services and support. The customers are located on a global level and the head office is located in Uppsala.
Omsætning
424,6 mio.
EBIT %
13,54 %
P/E
22,24
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
CRAD B
Daglig lav / høj pris
29,9 / 30,6
SEK
Markedsværdi
1,02 mia. SEK
Aktieomsætning
2,44 mio. SEK
Volumen
81 t
Seneste videoer
Finanskalender
Årsrapport
07.02.2025
Delårsrapport
07.05.2025
Generalforsamling
08.05.2025
Delårsrapport
18.07.2025
Delårsrapport
23.10.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Svea Bank AB | 11,9 % | 11,9 % |
Linc AB | 7,6 % | 11,9 % |
Avanza Pension | 5,0 % | 4,0 % |
Lars Kling | 4,2 % | 3,6 % |
Lars Nyberg | 4,2 % | 3,5 % |
Hamberg Förvaltning AB | 3,6 % | 11,1 % |
Nordnet Pensionsförsäkring AB | 3,6 % | 2,9 % |
Margareta Hamberg | 3,2 % | 2,6 % |
Cliens Funds | 2,3 % | 1,9 % |
Handelsbanken Funds | 2,1 % | 1,7 % |
ViserAlle indholdstyper
C-RAD’s Interim Report January-September 2024
C-RAD is advancing radiotherapy in Latin America in Mexico and wins 10 MSEK order
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools